Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis

OBJECTIVE—Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that...

Full description

Saved in:
Bibliographic Details
Published inArteriosclerosis, thrombosis, and vascular biology Vol. 36; no. 9; pp. 1782 - 1790
Main Authors Aarup, Annemarie, Pedersen, Tanja X, Junker, Nanna, Christoffersen, Christina, Bartels, Emil D, Madsen, Marie, Nielsen, Carsten H, Nielsen, Lars B
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract OBJECTIVE—Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice. APPROACH AND RESULTS—Studies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α–expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr recipient mice by ≈72% (P=0.006).In vitro, HIF-1α–deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages. CONCLUSIONS—HIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis.
AbstractList OBJECTIVE—Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice. APPROACH AND RESULTS—Studies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α–expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr recipient mice by ≈72% (P=0.006).In vitro, HIF-1α–deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages. CONCLUSIONS—HIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis.
OBJECTIVEAtherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice.APPROACH AND RESULTSStudies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α-expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr(-/-) mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr(-/-) recipient mice by ≈72% (P=0.006).In vitro, HIF-1α-deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages.CONCLUSIONSHIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis.
Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice. Studies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α-expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr(-/-) mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr(-/-) recipient mice by ≈72% (P=0.006).In vitro, HIF-1α-deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages. HIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis.
Objective— Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key transcription factor in cellular responses to hypoxia. We investigated the hypothesis that HIF-1α has effects on macrophage biology that promotes atherogenesis in mice. Approach and Results— Studies with molecular probes, immunostaining, and laser microdissection of aortas revealed abundant hypoxic, HIF-1α–expressing macrophages in murine atherosclerotic lesions. To investigate the significance of macrophage HIF-1α, Ldlr −/− mice were transplanted with bone marrow from mice with HIF-1α deficiency in the myeloid cells or control bone marrow. The HIF-1α deficiency in myeloid cells reduced atherosclerosis in aorta of the Ldlr −/− recipient mice by ≈72% ( P =0.006). In vitro, HIF-1α–deficient macrophages displayed decreased differentiation to proinflammatory M1 macrophages and reduced expression of inflammatory genes. HIF-1α deficiency also affected glucose uptake, apoptosis, and migratory abilities of the macrophages. Conclusions— HIF-1α expression in macrophages affects their intrinsic inflammatory profile and promotes development of atherosclerosis.
Author Junker, Nanna
Christoffersen, Christina
Aarup, Annemarie
Nielsen, Carsten H
Nielsen, Lars B
Pedersen, Tanja X
Bartels, Emil D
Madsen, Marie
AuthorAffiliation From the Department of Biomedical Sciences (A.A., T.X.P., N.J., C.C., M.M., C.H.N., L.B.N.) and Department of Clinical Medicine (L.B.N.), University of Copenhagen, Denmark; and Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark (C.C., E.D.B., L.B.N.)
AuthorAffiliation_xml – name: From the Department of Biomedical Sciences (A.A., T.X.P., N.J., C.C., M.M., C.H.N., L.B.N.) and Department of Clinical Medicine (L.B.N.), University of Copenhagen, Denmark; and Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark (C.C., E.D.B., L.B.N.)
Author_xml – sequence: 1
  givenname: Annemarie
  surname: Aarup
  fullname: Aarup, Annemarie
  organization: From the Department of Biomedical Sciences (A.A., T.X.P., N.J., C.C., M.M., C.H.N., L.B.N.) and Department of Clinical Medicine (L.B.N.), University of Copenhagen, Denmark; and Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Denmark (C.C., E.D.B., L.B.N.)
– sequence: 2
  givenname: Tanja
  surname: Pedersen
  middlename: X
  fullname: Pedersen, Tanja X
– sequence: 3
  givenname: Nanna
  surname: Junker
  fullname: Junker, Nanna
– sequence: 4
  givenname: Christina
  surname: Christoffersen
  fullname: Christoffersen, Christina
– sequence: 5
  givenname: Emil
  surname: Bartels
  middlename: D
  fullname: Bartels, Emil D
– sequence: 6
  givenname: Marie
  surname: Madsen
  fullname: Madsen, Marie
– sequence: 7
  givenname: Carsten
  surname: Nielsen
  middlename: H
  fullname: Nielsen, Carsten H
– sequence: 8
  givenname: Lars
  surname: Nielsen
  middlename: B
  fullname: Nielsen, Lars B
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27444197$$D View this record in MEDLINE/PubMed
BookMark eNp9kM1OwkAUhScGIz_6Ai5Ml26K88dMWVYEIcHogri0mba3Up126kwr8Fi-iM9kCejSzb33JOec5H591ClNCQhdEjwkRJCbcPV8G87DvRgyLAOGT1CPjCj3uWCi095Yjv2R4LSL-s69YYw5pfgMdanknJOx7KGX-a4y21z5izJtkjzW4M1UUhvrk-8vb7qtLDiXm9LLS-9BJdZUa_UKznuypjB1e9zBJ2hTFVDWnsm8sF6DNS7R-5m7c3SaKe3g4rgHaDWbriZzf_l4v5iESz9heIz9keSMKJECDiRXlMeUpjEEUggmRxlTqcwCqWKeyCwWFDIWcAkExywjQaJSNkDXh9rKmo8GXB0VuUtAa1WCaVxEAsKFaEHg1koP1vYX5yxkUWXzQtldRHC0xxodse5FdMDahq6O_U1cQPoX-eXYGsTBsDG6BuvedbMBG61B6Xr9X_MPqkuIKQ
CitedBy_id crossref_primary_10_1111_1755_5922_12262
crossref_primary_10_1002_advs_202207224
crossref_primary_10_1111_jcmm_13977
crossref_primary_10_1016_j_jacbts_2020_05_006
crossref_primary_10_1016_j_cmet_2017_06_001
crossref_primary_10_1016_j_biopha_2020_110338
crossref_primary_10_1016_j_mce_2020_110878
crossref_primary_10_1161_CIRCRESAHA_123_324086
crossref_primary_10_3390_biomedicines8110470
crossref_primary_10_1016_j_bioactmat_2020_09_005
crossref_primary_10_5483_BMBRep_2019_52_6_140
crossref_primary_10_1016_j_jacbts_2019_10_007
crossref_primary_10_1161_ATVBAHA_119_313290
crossref_primary_10_1016_j_pharmthera_2017_09_003
crossref_primary_10_1038_s41590_018_0113_3
crossref_primary_10_3390_ijms24010589
crossref_primary_10_1038_s41423_021_00791_9
crossref_primary_10_1186_s12974_023_02793_y
crossref_primary_10_1016_j_tips_2019_02_004
crossref_primary_10_1096_fj_202302001R
crossref_primary_10_1038_s41419_020_03372_2
crossref_primary_10_1186_s12967_017_1336_z
crossref_primary_10_3390_cells9020336
crossref_primary_10_1186_s13020_022_00658_9
crossref_primary_10_1084_jem_20200667
crossref_primary_10_1007_s10456_021_09816_3
crossref_primary_10_1007_s00109_018_1710_1
crossref_primary_10_1161_CIRCRESAHA_119_315939
crossref_primary_10_1172_JCI137557
crossref_primary_10_20900_immunometab20210017
crossref_primary_10_1007_s40620_022_01432_8
crossref_primary_10_3389_fimmu_2019_02951
crossref_primary_10_1016_j_redox_2022_102504
crossref_primary_10_3390_cells9010195
crossref_primary_10_1161_ATVBAHA_120_314037
crossref_primary_10_1096_fj_202201486R
crossref_primary_10_1016_j_semnephrol_2018_02_006
crossref_primary_10_3390_ijtm1010004
crossref_primary_10_3390_ijms242115866
crossref_primary_10_1097_MOL_0000000000000550
crossref_primary_10_1536_ihj_21_233
crossref_primary_10_3390_ijms22168992
crossref_primary_10_1038_s41392_023_01652_9
crossref_primary_10_1016_j_molimm_2022_06_003
crossref_primary_10_1152_ajprenal_00418_2017
crossref_primary_10_1016_j_cdtm_2021_05_001
crossref_primary_10_1002_adtp_202100232
crossref_primary_10_1016_j_jpha_2023_11_016
crossref_primary_10_1016_j_mam_2020_100922
crossref_primary_10_1016_j_ccl_2021_04_003
crossref_primary_10_2967_jnumed_120_245407
crossref_primary_10_1016_j_intimp_2021_108413
crossref_primary_10_1038_s44161_024_00473_5
crossref_primary_10_3389_fimmu_2022_868958
crossref_primary_10_1039_D2TB00811D
crossref_primary_10_1161_JAHA_123_033109
crossref_primary_10_1016_j_intimp_2023_110305
crossref_primary_10_1080_17435390_2021_1917716
crossref_primary_10_1080_14740338_2023_2285889
crossref_primary_10_3390_antiox11112183
crossref_primary_10_1007_s00395_018_0686_x
crossref_primary_10_3390_cells11162586
crossref_primary_10_1080_17435390_2022_2083995
crossref_primary_10_1024_0301_1526_a001044
crossref_primary_10_1111_odi_13856
crossref_primary_10_1002_iub_2667
crossref_primary_10_1016_j_ejphar_2017_09_012
crossref_primary_10_1161_ATVBAHA_118_311806
crossref_primary_10_1016_j_biopha_2023_114333
crossref_primary_10_1097_MOL_0000000000000539
crossref_primary_10_1016_j_phrs_2022_106081
crossref_primary_10_3389_fimmu_2024_1402468
crossref_primary_10_3390_biomedicines11061734
crossref_primary_10_1093_cvr_cvab152
crossref_primary_10_1038_s41419_023_06206_z
crossref_primary_10_1016_j_intimp_2019_106150
crossref_primary_10_1073_pnas_1618411114
crossref_primary_10_3390_biomedicines9040328
crossref_primary_10_1161_ATVBAHA_119_312287
crossref_primary_10_1016_j_heliyon_2023_e17167
crossref_primary_10_1016_j_cca_2022_07_004
crossref_primary_10_3390_jcm11216465
crossref_primary_10_1038_s41598_017_06816_6
crossref_primary_10_1016_j_ejphar_2017_04_028
crossref_primary_10_1007_s00281_017_0656_7
crossref_primary_10_1111_imr_13214
crossref_primary_10_1007_s00424_017_1941_y
crossref_primary_10_1016_j_cyto_2018_02_002
crossref_primary_10_1093_cvr_cvz107
crossref_primary_10_4049_jimmunol_2300293
crossref_primary_10_1097_MOL_0000000000000634
crossref_primary_10_1016_j_surg_2016_11_009
crossref_primary_10_1038_s41467_022_32871_3
crossref_primary_10_1038_s41598_020_77793_6
crossref_primary_10_3390_ijms231911488
crossref_primary_10_1161_ATVBAHA_117_309228
crossref_primary_10_1007_s11882_019_0871_5
crossref_primary_10_1177_1708538120904297
crossref_primary_10_20900_immunometab20200028
crossref_primary_10_1016_j_arr_2023_101993
crossref_primary_10_4103_MJ_MJ_12_19
crossref_primary_10_1097_MCA_0000000000001142
crossref_primary_10_1002_1873_3468_12786
Cites_doi 10.1161/ATVBAHA.108.183319
10.1161/ATVBAHA.115.305551
10.1073/pnas.0403259101
10.1038/35017054
10.1161/ATVBAHA.115.307136
10.1007/s007950200023
10.1681/ASN.2014111139
10.1038/ncpcardio1247
10.1016/j.atherosclerosis.2007.05.026
10.1074/jbc.M113.522037
10.1161/01.ATV.7.3.238
10.1172/JCI23865
10.1093/ndt/gfv302
10.1038/cdd.2008.12
10.1016/S1471-4914(01)02090-1
10.1073/pnas.0511043103
10.4049/jimmunol.165.6.3430
10.1681/ASN.2015030241
10.1016/S0368-1319(69)80005-0
10.1073/pnas.92.12.5510
10.1136/jclinpath-2012-200828
10.1161/ATVBAHA.115.306171
10.1182/blood.V94.5.1561
10.1097/MOL.0b013e3283307be8
10.1161/CIRCRESAHA.111.246363
10.1042/bj3500307
10.7326/0003-4819-71-2-426
10.4049/jimmunol.178.12.7516
10.1161/01.ATV.17.11.2479
10.1146/annurev.immunol.021908.132532
10.1016/j.jacc.2007.12.025
10.1096/fj.13-235911
10.1038/20459
10.1016/S0006-2952(02)01155-3
10.1126/science.1059817
10.1038/nm1102-1235
10.1073/pnas.080072497
10.2741/3168
10.1038/nature10146
10.1016/S0368-1319(69)80023-2
10.1016/0021-9150(72)90051-2
10.1038/nature01323
10.1038/35025220
10.1038/nrc1187
10.1189/jlb.0908536
10.1016/j.ejphar.2007.01.066
10.1182/blood-2002-09-2711
10.1161/JAHA.114.001232
10.1194/jlr.M050633
10.1016/0021-9150(73)90027-0
10.1161/ATVBAHA.115.306861
10.1016/j.cardiores.2006.09.005
10.1016/S0092-8674(03)00154-5
10.1097/MOL.0b013e32833ded6a
10.3171/JNS/2008/109/7/0083
10.1074/jbc.272.36.22642
10.1194/jlr.R800032-JLR200
10.1161/ATVBAHA.111.235788
10.1002/jcb.25074
10.1161/01.ATV.19.4.870
10.1093/emboj/19.16.4298
10.1161/ATVBAHA.110.221440
10.1016/S0021-9258(17)31580-6
10.3758/BRM.40.3.879
10.1161/01.ATV.0000184783.04864.9f
10.1038/bjc.1995.429
10.1016/j.jacc.2011.03.044
ContentType Journal Article
Copyright 2016 American Heart Association, Inc.
Copyright_xml – notice: 2016 American Heart Association, Inc.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1161/ATVBAHA.116.307830
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4636
EndPage 1790
ExternalDocumentID 10_1161_ATVBAHA_116_307830
27444197
10.1161/ATVBAHA.116.307830
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
.Z2
01R
08R
0R
1J1
23N
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
55
5GY
5RE
5VS
71W
77Y
7O
7O~
AAAXR
AAMOA
AAMTA
AAPBV
AARTV
AAXQO
ABBUW
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACGOD
ACPRK
ACWDW
ACWRI
ACXNZ
ADACO
ADBBV
ADFPA
ADNKB
AE3
AENEX
AFFNX
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
AJNYG
AJYGW
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
AWKKM
BAWUL
BOYCO
C1A
C45
CS3
DIK
DUNZO
E.X
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
FL-
FRP
FW0
GJ
GX1
H0
H0~
H13
HZ
IKYAY
IN
IN~
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
LI0
N9A
N~7
N~B
N~M
O0-
O9-
OAG
OAH
OB2
OCUKA
ODA
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWW
OWY
OXXIT
P-K
P2P
PQEST
PQQKQ
PZZ
RAH
RHF
RIG
RLZ
RSW
S4R
S4S
V2I
WOQ
WOW
X3V
X3W
X7M
Z2
ZA5
ZGI
---
.3C
.55
.GJ
0R~
AAAAV
AAGIX
AAHPQ
AAIQE
AAQKA
AASCR
AASOK
ABASU
ABDIG
ABJNI
ABQRW
ABVCZ
ACCJW
ACILI
ACLDA
ACXJB
ADGGA
ADHPY
AE6
AEETU
AFDTB
AGINI
AHJKT
AHOMT
AHQNM
AHRYX
AINUH
AJNWD
AJZMW
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
AYCSE
BQLVK
BS7
CGR
CUY
CVF
DIWNM
ECM
EEVPB
EIF
ERAAH
FCALG
GNXGY
GQDEL
HLJTE
HZ~
IKREB
IPNFZ
NPM
OWU
OWV
OWX
OWZ
T8P
TEORI
TR2
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
ZZMQN
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c3090-57431a6de0874a24b22dbe8766375f3ad7f87ab4c7fb62ef3847e10b3f18cad3
ISSN 1079-5642
IngestDate Sat Oct 26 00:39:44 EDT 2024
Fri Aug 23 01:19:02 EDT 2024
Wed Oct 16 00:59:07 EDT 2024
Thu Aug 13 19:46:46 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords atherosclerosis
hypoxia-inducible factor 1α
hypoxia
apoptosis
macrophage
Language English
License 2016 American Heart Association, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3090-57431a6de0874a24b22dbe8766375f3ad7f87ab4c7fb62ef3847e10b3f18cad3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.116.307830
PMID 27444197
PQID 1814666420
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1814666420
crossref_primary_10_1161_ATVBAHA_116_307830
pubmed_primary_27444197
wolterskluwer_health_10_1161_ATVBAHA_116_307830
ProviderPackageCode L-C
C45
7O~
AARTV
ADFPA
OLH
ASCII
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
OVLEI
AJIOK
OPUJH
V2I
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
OB2
ACEWG
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OUVQU
ORVUJ
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
AAMTA
AAAXR
E.X
OWW
OCUKA
OWY
01R
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
FW0
PublicationCentury 2000
PublicationDate 2016-September
2016-09-00
20160901
PublicationDateYYYYMMDD 2016-09-01
PublicationDate_xml – month: 09
  year: 2016
  text: 2016-September
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Arteriosclerosis, thrombosis, and vascular biology
PublicationTitleAlternate Arterioscler Thromb Vasc Biol
PublicationYear 2016
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References e_1_3_5_27_2
e_1_3_5_25_2
e_1_3_5_23_2
e_1_3_5_21_2
e_1_3_5_44_2
e_1_3_5_65_2
e_1_3_5_46_2
e_1_3_5_67_2
e_1_3_5_48_2
e_1_3_5_69_2
e_1_3_5_29_2
e_1_3_5_40_2
e_1_3_5_61_2
e_1_3_5_42_2
e_1_3_5_63_2
e_1_3_5_7_2
e_1_3_5_9_2
e_1_3_5_3_2
e_1_3_5_5_2
e_1_3_5_39_2
e_1_3_5_16_2
e_1_3_5_37_2
e_1_3_5_14_2
e_1_3_5_12_2
e_1_3_5_35_2
e_1_3_5_10_2
e_1_3_5_33_2
e_1_3_5_54_2
e_1_3_5_56_2
e_1_3_5_58_2
e_1_3_5_18_2
e_1_3_5_50_2
Mendis S (e_1_3_5_2_2) 2011
e_1_3_5_52_2
e_1_3_5_31_2
e_1_3_5_28_2
e_1_3_5_26_2
e_1_3_5_24_2
e_1_3_5_22_2
e_1_3_5_43_2
e_1_3_5_66_2
e_1_3_5_45_2
e_1_3_5_68_2
e_1_3_5_47_2
e_1_3_5_49_2
e_1_3_5_60_2
e_1_3_5_62_2
e_1_3_5_41_2
e_1_3_5_64_2
e_1_3_5_8_2
e_1_3_5_20_2
e_1_3_5_4_2
e_1_3_5_6_2
e_1_3_5_17_2
e_1_3_5_38_2
e_1_3_5_15_2
e_1_3_5_36_2
e_1_3_5_13_2
e_1_3_5_34_2
e_1_3_5_11_2
e_1_3_5_32_2
e_1_3_5_55_2
e_1_3_5_57_2
e_1_3_5_59_2
e_1_3_5_19_2
e_1_3_5_51_2
e_1_3_5_53_2
e_1_3_5_30_2
References_xml – ident: e_1_3_5_36_2
  doi: 10.1161/ATVBAHA.108.183319
– ident: e_1_3_5_63_2
  doi: 10.1161/ATVBAHA.115.305551
– ident: e_1_3_5_53_2
  doi: 10.1073/pnas.0403259101
– ident: e_1_3_5_25_2
  doi: 10.1038/35017054
– ident: e_1_3_5_47_2
  doi: 10.1161/ATVBAHA.115.307136
– ident: e_1_3_5_4_2
  doi: 10.1007/s007950200023
– ident: e_1_3_5_67_2
  doi: 10.1681/ASN.2014111139
– ident: e_1_3_5_3_2
  doi: 10.1038/ncpcardio1247
– ident: e_1_3_5_39_2
  doi: 10.1016/j.atherosclerosis.2007.05.026
– ident: e_1_3_5_62_2
  doi: 10.1074/jbc.M113.522037
– ident: e_1_3_5_17_2
  doi: 10.1161/01.ATV.7.3.238
– ident: e_1_3_5_35_2
  doi: 10.1172/JCI23865
– ident: e_1_3_5_69_2
  doi: 10.1093/ndt/gfv302
– ident: e_1_3_5_28_2
  doi: 10.1038/cdd.2008.12
– ident: e_1_3_5_19_2
  doi: 10.1016/S1471-4914(01)02090-1
– ident: e_1_3_5_54_2
  doi: 10.1073/pnas.0511043103
– ident: e_1_3_5_65_2
  doi: 10.4049/jimmunol.165.6.3430
– ident: e_1_3_5_68_2
  doi: 10.1681/ASN.2015030241
– ident: e_1_3_5_44_2
  doi: 10.1016/S0368-1319(69)80005-0
– ident: e_1_3_5_20_2
  doi: 10.1073/pnas.92.12.5510
– ident: e_1_3_5_29_2
  doi: 10.1136/jclinpath-2012-200828
– ident: e_1_3_5_46_2
  doi: 10.1161/ATVBAHA.115.306171
– ident: e_1_3_5_57_2
  doi: 10.1182/blood.V94.5.1561
– ident: e_1_3_5_11_2
  doi: 10.1097/MOL.0b013e3283307be8
– ident: e_1_3_5_31_2
  doi: 10.1161/CIRCRESAHA.111.246363
– ident: e_1_3_5_58_2
  doi: 10.1042/bj3500307
– ident: e_1_3_5_12_2
  doi: 10.7326/0003-4819-71-2-426
– ident: e_1_3_5_34_2
  doi: 10.4049/jimmunol.178.12.7516
– ident: e_1_3_5_64_2
  doi: 10.1161/01.ATV.17.11.2479
– ident: e_1_3_5_66_2
  doi: 10.1146/annurev.immunol.021908.132532
– ident: e_1_3_5_15_2
  doi: 10.1016/j.jacc.2007.12.025
– ident: e_1_3_5_6_2
  doi: 10.1096/fj.13-235911
– ident: e_1_3_5_24_2
  doi: 10.1038/20459
– ident: e_1_3_5_51_2
  doi: 10.1016/S0006-2952(02)01155-3
– ident: e_1_3_5_23_2
  doi: 10.1126/science.1059817
– ident: e_1_3_5_10_2
  doi: 10.1038/nm1102-1235
– ident: e_1_3_5_26_2
  doi: 10.1073/pnas.080072497
– ident: e_1_3_5_40_2
  doi: 10.2741/3168
– ident: e_1_3_5_9_2
  doi: 10.1038/nature10146
– ident: e_1_3_5_13_2
  doi: 10.1016/S0368-1319(69)80023-2
– ident: e_1_3_5_18_2
  doi: 10.1016/0021-9150(72)90051-2
– ident: e_1_3_5_5_2
  doi: 10.1038/nature01323
– ident: e_1_3_5_14_2
  doi: 10.1038/35025220
– ident: e_1_3_5_21_2
  doi: 10.1038/nrc1187
– ident: e_1_3_5_55_2
  doi: 10.1189/jlb.0908536
– ident: e_1_3_5_30_2
  doi: 10.1016/j.ejphar.2007.01.066
– ident: e_1_3_5_56_2
  doi: 10.1182/blood-2002-09-2711
– ident: e_1_3_5_8_2
  doi: 10.1161/JAHA.114.001232
– ident: e_1_3_5_7_2
  doi: 10.1194/jlr.M050633
– ident: e_1_3_5_45_2
  doi: 10.1016/0021-9150(73)90027-0
– ident: e_1_3_5_37_2
  doi: 10.1161/ATVBAHA.115.306861
– ident: e_1_3_5_49_2
  doi: 10.1016/j.cardiores.2006.09.005
– ident: e_1_3_5_33_2
  doi: 10.1016/S0092-8674(03)00154-5
– ident: e_1_3_5_52_2
  doi: 10.1097/MOL.0b013e32833ded6a
– ident: e_1_3_5_38_2
  doi: 10.3171/JNS/2008/109/7/0083
– ident: e_1_3_5_22_2
  doi: 10.1074/jbc.272.36.22642
– start-page: 8
  volume-title: In: Global Atlas on Cardiovascular Disease Prevention and Control
  year: 2011
  ident: e_1_3_5_2_2
  contributor:
    fullname: Mendis S
– ident: e_1_3_5_50_2
  doi: 10.1194/jlr.R800032-JLR200
– ident: e_1_3_5_32_2
  doi: 10.1161/ATVBAHA.111.235788
– ident: e_1_3_5_59_2
  doi: 10.1002/jcb.25074
– ident: e_1_3_5_16_2
  doi: 10.1161/01.ATV.19.4.870
– ident: e_1_3_5_27_2
  doi: 10.1093/emboj/19.16.4298
– ident: e_1_3_5_41_2
  doi: 10.1161/ATVBAHA.110.221440
– ident: e_1_3_5_60_2
  doi: 10.1016/S0021-9258(17)31580-6
– ident: e_1_3_5_43_2
  doi: 10.3758/BRM.40.3.879
– ident: e_1_3_5_48_2
  doi: 10.1161/01.ATV.0000184783.04864.9f
– ident: e_1_3_5_42_2
  doi: 10.1038/bjc.1995.429
– ident: e_1_3_5_61_2
  doi: 10.1016/j.jacc.2011.03.044
SSID ssj0004220
Score 2.469551
Snippet OBJECTIVE—Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a...
Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a key...
Objective— Atherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is...
OBJECTIVEAtherosclerotic lesions contain hypoxic areas, but the pathophysiological importance of hypoxia is unknown. Hypoxia-inducible factor-1α (HIF-1α) is a...
SourceID proquest
crossref
pubmed
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1782
SubjectTerms Animals
Aorta, Thoracic - metabolism
Aorta, Thoracic - pathology
Aortic Diseases - genetics
Aortic Diseases - metabolism
Aortic Diseases - pathology
Apolipoproteins E - deficiency
Apolipoproteins E - genetics
Apoptosis
Atherosclerosis - genetics
Atherosclerosis - metabolism
Atherosclerosis - pathology
Bone Marrow Transplantation
Cell Differentiation
Cell Hypoxia
Cell Movement
Cells, Cultured
Cholesterol - metabolism
Disease Models, Animal
Disease Progression
Foam Cells - metabolism
Foam Cells - pathology
Genetic Predisposition to Disease
Glucose - metabolism
Hypoxia-Inducible Factor 1, alpha Subunit - deficiency
Hypoxia-Inducible Factor 1, alpha Subunit - genetics
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
Inflammation Mediators - metabolism
Mice, Inbred C57BL
Mice, Knockout
Phenotype
Plaque, Atherosclerotic
Receptors, LDL - deficiency
Receptors, LDL - genetics
Signal Transduction
Title Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis
URI https://www.ncbi.nlm.nih.gov/pubmed/27444197
https://search.proquest.com/docview/1814666420
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBATQtwpNwWJPU3Z4jhxmsdualXBOkDKUJ-I7MQRYVpSrY24_Ad-DH-E38Q5sXMZndDgJYrd1pZ8vp5L8p1zCHmVuqkSYBrsIGMQoAQis6VMPJtJLwml9MFmYnLy_JjPTrzXC38xGPzosZaqtdxLvl-aV_I_UoU5kCtmyf6DZNtFYQLuQb5wBQnD9Uoynn1bll9zYWP_jSTHHKhp3T7HpjuHk50DioWMNc-15jPOBfbr-iSwrMO7moYHNz3WUO2VokNYrmAjuOarvu86RvZn3n2G0sEuC2eyGeFD-Jbaaso7tYgS59VSUygLdYYReqeVkUyt1V8kis9id9HyeqrCsD7AChQdqUhXRMDWLuZ3esa0Am-eYlDe0rTACBnNC4DB6mV91WxGGoJhT8_SQLcsMjYby4xdbg842oNx9OFgPBvjcI_he0uns37NG__jt_H05OgojiaL6Bq57oLeQoX55n2v-LzrOk3eFaf7m6te9G02ApZtcutLiRyI1WmdAtFzZKI75LaJQKyxhtNdMlDFPXJjbjgW98nHDVRZDap-_bQ6RFl5YfUQZTWIsnqIssrM-gNRD0g0nUSHM9t04bAT5oSO7aOPKXiqnFHgCdeTrptKBUaUs8DPmEiDbBQI-GsHmeSuyhj4O4o6kmV0lIiUPSRbRVmox8QSEC4nCeUJlZ7HZRIy4cuUpo4acRmwbEh2m-OLl7rWSlzHqJzG5rBxEOvDHpKXzQnHoBLxPZcoVFmtYoqPtTkE1vCdR_ro2_WwIKZHw2BI9i_IItZpx3_Z78kV9ntKbnbgfka21ueVeg5O61q-qKH0G4rinZU
link.rule.ids 315,783,787,27936,27937
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxia-Inducible+Factor-1%CE%B1+Expression+in+Macrophages+Promotes+Development+of+Atherosclerosis&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Aarup%2C+Annemarie&rft.au=Pedersen%2C+Tanja+X&rft.au=Junker%2C+Nanna&rft.au=Christoffersen%2C+Christina&rft.date=2016-09-01&rft.eissn=1524-4636&rft.volume=36&rft.issue=9&rft.spage=1782&rft.epage=1790&rft_id=info:doi/10.1161%2FATVBAHA.116.307830&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon